Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metronidazole vaginal gel before elective hysterectomy for prevention of surgical site infection
IRCT20200217046523N9Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of metronidazole in surgical site infection (SSI) (2 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoint: Infection. Started Jan 2021; status: completed.
02
Drugs
metronidazole
03
Conditions
surgical site infection (SSI)
Beyond the preview
Go deeper on IRCT20200217046523N9.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200217046523N9.